Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 Hyperimmune IVIG in Hospitalized Adults With Clinical Progression
2020-002542-16Phase 3Unknown
- Sponsor
- University of Minnesota
- Start
- Sep 2020
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Anti-COVID-19 hyperimmune globulin with Placebo (2 arms). Primary endpoint: Clinical status ordinal outcome on Day 7. Status: unknown.
02
Drugs
CoviGlobulin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002542-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002542-16.